To assess as to whether or not Noxa up‐regulation is pivotal for the cell death induction of the combination therapy (ABT263 and LXR623), we silenced the expression of Noxa, using two Noxa‐specific siRNAs, in LN229 GBM cells (Fig 3C). Here, PMAIP1 is linked to glioblastoma.